Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Safety of vitamin D replacement in patients with primary hyperparathyroidism and concomitant vitamin D deficiency.

Wagner D, Xia Y, Hou R.

Endocr Pract. 2013 May-Jun;19(3):420-5. doi: 10.4158/EP12155.OR.

PMID:
23337136
2.

Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.

Shah VN, Shah CS, Bhadada SK, Rao DS.

Clin Endocrinol (Oxf). 2014 Jun;80(6):797-803. doi: 10.1111/cen.12398. Epub 2014 Jan 28. Review.

PMID:
24382124
3.

Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapy.

Mikhail N.

South Med J. 2011 Jan;104(1):29-33. doi: 10.1097/SMJ.0b013e3181fcd772. Review.

PMID:
21079532
5.

[Review of the concept of vitamin D "sufficiency and insufficiency"].

Gómez Alonso C, Naves Díaz M, Rodríguez García M, Fernández Martín JL, Cannata Andía JB.

Nefrologia. 2003;23 Suppl 2:73-7. Review. Spanish.

6.

Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.

Lau KH, Baylink DJ.

Calcif Tissue Int. 1999 Oct;65(4):295-306. Review.

PMID:
10485982
7.

Vitamin D treatment in primary hyperparathyroidism.

Rolighed L, Bollerslev J, Mosekilde L.

Curr Drug Saf. 2011 Apr;6(2):100-7. Review.

PMID:
21524245
8.

Vitamin D deficiency and primary hyperparathyroidism.

Silverberg SJ.

J Bone Miner Res. 2007 Dec;22 Suppl 2:V100-4. doi: 10.1359/jbmr.07s202. Review.

9.

Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism.

Bollerslev J, Marcocci C, Sosa M, Nordenström J, Bouillon R, Mosekilde L.

Eur J Endocrinol. 2011 Dec;165(6):851-64. doi: 10.1530/EJE-11-0589. Epub 2011 Sep 29. Review.

Supplemental Content

Support Center